about
Targeting of MAPK-associated molecules identifies SON as a prime target to attenuate the proliferation and tumorigenicity of pancreatic cancer cellsPotential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancerImpacts of activation of the mitogen-activated protein kinase pathway in pancreatic cancerA Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreasp24/ING1-ALT1 and p47/ING1-ALT2, distinct alternative transcripts of p33/ING1Abrogation of DUSP6 by hypermethylation in human pancreatic cancerPTEN1 is frequently mutated in primary endometrial carcinomasMutation of junctophilin type 2 associated with hypertrophic cardiomyopathyGenomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma.Whole-exome sequencing identifies a de novo TUBA1A mutation in a patient with sporadic malformations of cortical development: a case report.Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreasWhole exome sequencing reveals recurrent mutations in BRCA2 and FAT genes in acinar cell carcinomas of the pancreas.Single nucleotide variations in CLCN6 identified in patients with benign partial epilepsies in infancy and/or febrile seizures.Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas.Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune PancreatitisClassification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study.Molecular mechanisms of pancreatic carcinogenesis.Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations.Original Scientific Reports: Clinicopathological Findings of Remnant Pancreatic Cancers in Survivors Following Curative Resections of Pancreatic Cancers.Molecular genetics of intraductal papillary-mucinous neoplasms of the pancreas.A GNAS mutation found in pancreatic intraductal papillary mucinous neoplasms induces drastic alterations of gene expression profiles with upregulation of mucin genes.Germline mutations in Japanese familial pancreatic cancer patients.The role of chromosome 18 abnormalities in the progression of pancreatic adenocarcinoma.Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma.ENBD is Associated with Decreased Tumor Dissemination Compared to PTBD in Perihilar Cholangiocarcinoma.Relationship between pancreatic intraepithelial neoplasias, pancreatic ductal adenocarcinomas, and single nucleotide polymorphisms in autopsied elderly patients.High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.Transrepression activity of T-box1 in a gene regulation network in mouse cells.MicroRNAs associated with mitogen-activated protein kinase in human pancreatic cancer.Upregulation of IGF2 is associated with an acquired resistance for cis-diamminedichloroplatinum in human head and neck squamous cell carcinoma.RNA interference targeting against S100A4 suppresses cell growth and motility and induces apoptosis in human pancreatic cancer cells.Feedback regulation of DUSP6 transcription responding to MAPK1 via ETS2 in human cells.Transcriptional silencing of ETS-1 efficiently suppresses angiogenesis of pancreatic cancer.The PMAIP1 gene on chromosome 18 is a candidate tumor suppressor gene in human pancreatic cancer.RNA interference targeting aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells.Chromosome 12, frequently deleted in human pancreatic cancer, may encode a tumor-suppressor gene that suppresses angiogenesis.APAF-1-ALT, a novel alternative splicing form of APAF-1, potentially causes impeded ability of undergoing DNA damage-induced apoptosis in the LNCaP human prostate cancer cell line.GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm.A long-term recurrence-free survival of a patient with the mixed adeno-neuroendocrine bile duct carcinoma: A case report and review of the literature.
P50
Q21245757-88D2FF6D-C9CE-45C5-82CA-74ED110C3785Q24685746-F1C18032-1872-4057-B3B0-11C5AAF5E7A4Q26830681-08E7566C-1F4E-49C4-8BE6-BE2A7F92BAB2Q28082890-AE1ABD54-D3F0-423B-AA2D-94898E16EAF3Q28144237-0C14C1C3-DF83-4D16-BAE0-3731F96D7E53Q28244702-B9AA5420-2785-4012-B960-FE0316E853C0Q28250937-90740651-6F64-4FF6-AAF8-15560E5C1772Q28300361-37EBB672-2BF5-46BE-85A7-CCE05DC006C3Q33888432-1FD63294-6B75-4255-8AAD-F28DAD42C558Q33988618-C285F006-20E2-4220-87ED-0F87E1BA4B16Q34100230-D6D81817-EB98-4C6D-A230-5ADFA02534F1Q35153241-E8E91AED-0C72-4349-B163-00521BF424DCQ35201817-E920D401-3B6B-4745-A224-C1225A4D437FQ35619635-11662C25-29B2-4208-94E9-E33CEDB2D765Q36055277-490A590B-8BAF-4AB7-A005-67D975CB1958Q36068268-67E6CA48-A5A5-4389-9837-044B259CD39AQ36222863-78AA14A5-3D7A-4237-9542-681F0E4BE440Q36347882-58F1603B-11A1-4DFA-9571-BA7248C32657Q36362278-0674628A-FD7B-4EF9-99FC-0A583CF7BC22Q36620479-BFB278C3-BBED-4B54-9E59-33F0AB2078A4Q36829529-38C74E1E-3EB6-4254-9929-5B0D65DECC56Q37549140-9EB96D5E-5CF2-46F1-9606-38A6B2BE4990Q37687547-9A2A09DB-17AA-4629-BCEE-6015598FFBDCQ38342441-654F7F98-2429-451A-B110-A6F6BD63B8B3Q38646960-1B5590BD-5E90-43B7-B010-6CC7EE1556D6Q38672922-0E2D12A3-C184-469E-AD2F-8353FBD291F7Q38714426-70D7E388-8461-4772-BD55-3CCC8F85D531Q38761972-60D518B6-AD1B-4CB2-928E-C96782EF417AQ39277936-C935554B-CC55-494E-BF09-79349BAA296DQ39424517-88FEDE99-BAE5-4B95-BFC2-0BFDAC10459AQ39707564-C0B03F7E-4CFF-4F0B-8330-C5C392D714C1Q39792276-418E339B-EBF9-49C6-9CD3-57F96D48DC0BQ39930434-1AFDAA08-37E1-43D4-90D3-9E8F528202DCQ39942992-138408E7-6070-4361-85B0-389D673E39A1Q40019035-31390B8B-A4C5-4348-9A6C-DE66A3CB012BQ40439740-F2295418-1961-4D12-AD6A-AF9128EBA15EQ40527404-C519292F-5382-4508-BBD8-1FD15E1E792EQ40640047-A3EEF44F-F0D2-4F1C-AE74-73A9663B7903Q40643218-4F22D725-1849-4636-92F9-329C31BAA407Q41375872-74736310-7466-4757-8109-7497360DE5BF
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Toru Furukawa
@ast
Toru Furukawa
@en
Toru Furukawa
@es
Toru Furukawa
@nl
Toru Furukawa
@sl
type
label
Toru Furukawa
@ast
Toru Furukawa
@en
Toru Furukawa
@es
Toru Furukawa
@nl
Toru Furukawa
@sl
prefLabel
Toru Furukawa
@ast
Toru Furukawa
@en
Toru Furukawa
@es
Toru Furukawa
@nl
Toru Furukawa
@sl
P108
P106
P1153
35392252000
P31
P496
0000-0002-1083-2324